Nina Finkelstein

This inventor holds 27 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 1997-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nina Finkelstein. Retrieved from https://idiyas.com/inventor/nina-finkelstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 27 (Patent Applications = 6)

% Patents Active = 22.2

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 51(Granted Patents)

Location History:

Jerusalem, IL (1997 - 2003)
Herzliya, IS (2010)
Herzliya, IL (2001 - 2013)

Company Filing History:

27 out of 505

Teva Pharmaceutical Industries Limited

patents

Years Active: 1997-2013

Loading Chart...

Areas of Expertise:

Rosuvastatin

Aliskiren Compounds

Pantoprazole Sodium

Cilostazol

Lansoprazole

Alendronate Sodium

Piperazine Compounds

N-Methylparoxetine

Polyamine Derivatives

Impurity Reduction

Crystallization Processes

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8487097 - Reference standard for characterization of rosuvastatin (2013-07-16),

2. 8148576 - Solid state forms of aliskiren compounds (2012-04-03),

3. 7915423 - Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates (2011-03-29),

4. 7741482 - Reference standard for characterization of rosuvastatin (2010-06-22),

5. 7692010 - Reference standard for characterization of rosuvastatin (2010-04-06),

6. 7692009 - Reference standard for characterization of rosuvastatin (2010-04-06),

7. 7692008 - Reference standard for characterization of rosuvastatin (2010-04-06),

8. 7683177 - Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole (2010-03-23),

9. 7674923 - Process for preparing forms of atorvastatin calcium substantially free of impurities (2010-03-09),

10. 7622588 - Method for the purification of lansoprazole (2009-11-24),

11. 7507829 - Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates (2009-03-24),

12. 7244844 - Reference standard for characterization of rosuvastatin (2007-07-17),

13. 7067669 - Substantially pure cilostazol and processes for making same (2006-06-27),

14. 7064208 - Substantially pure cilostazol and processes for making same (2006-06-20),

15. 7060837 - Method for the purification of lansoprazole (2006-06-13),

Title: The Innovative Journey of Nina Finkelstein

Introduction: Nina Finkelstein, a pioneering inventor hailing from Herzliya, Israel, has made significant contributions to the world of technology and innovation.

Latest Patents: Nina Finkelstein's latest patents focus on cutting-edge advancements in artificial intelligence and renewable energy technologies, showcasing her commitment to creating a sustainable future.

Career Highlights: With a career spanning over two decades, Nina Finkelstein has established herself as a leading figure in the field of innovation. Her work has been recognized globally for its ingenuity and impact.

Collaborations: Throughout her career, Nina Finkelstein has collaborated with top research institutions, universities, and tech companies to bring her inventions to life. Her collaborative spirit has led to groundbreaking discoveries and advancements in various industries.

Conclusion: Nina Finkelstein's passion for innovation and dedication to creating a better world through her inventions make her a true trailblazer in the field. Her work continues to inspire future generations of inventors and innovators worldwide.

Profile summary based on public USPTO records.